CONMED Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

CONMED Stock Summary

CONMED competes with Orthopediatrics Corp, Pulmonx Corp, Si Bone, Globus Medical, and Orthofix Medical. CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida. C O operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 3800 people.

CONMED Key Financial Ratios

CONMED Key Balance Sheet Accounts

CONMED Key Income Statement Accounts

CONMED Key Cash Accounts

CONMED Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining CONMED's current stock value. Our valuation model uses many indicators to compare CONMED value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CONMED competition to find correlations between indicators driving CONMED's intrinsic value. More Info.CONMED is number one stock in return on equity category among its peers. It is rated fourth in return on asset category among its peers reporting about  0.29  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for CONMED is roughly  3.41 . At present, CONMED's Return On Equity is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value CONMED by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

CONMED Systematic Risk

Today, most investors in CONMED Stock are looking for potential investment opportunities by analyzing not only static indicators but also various CONMED's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of CONMED growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of CONMED help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of CONMED. We use our internally-developed statistical techniques to arrive at the intrinsic value of CONMED based on widely used predictive technical indicators. In general, we focus on analyzing CONMED Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build CONMED's daily price indicators and compare them against related drivers.

When running CONMED's price analysis, check to measure CONMED's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CONMED is operating at the current time. Most of CONMED's value examination focuses on studying past and present price action to predict the probability of CONMED's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CONMED's price. Additionally, you may evaluate how the addition of CONMED to your portfolios can decrease your overall portfolio volatility.